Category: Biotechnology

The Chief Executive Officer of Palantir confidently says that terrorist strategy gets hindered once a week in Europe.

Palantir was established by Peter Thiel. It is a firm that analyzes data. The chief executive officer of Palantir says that terrorist plot hindered each week in Europe Terrorist outbreaks are being hindered in Europe almost every week, as the Chief Executive Officer of Palantir fixated on domestic security. The CEO of the Silicon Valley-based

Mayo Clinic declares the inauguration of the first-ever hospital outside the premises of the United States.

Quoting common ideas and values, Mayo Clinic declared on Sunday the inauguration of its first hospital outside the premises of the United States, a joint venture with Abu Dhabi Health Services organization (SEHA) in Abu Dhabi, UAE. The hospital will be named Sheikh Shakhbout Medical City (SSMC). Just like the Mayo Clinic situated in Rochester,

Bacteria to augment global warming, study suggests

Amidst the continuous climate change debate, a new research suggests that bacteria may augment the phenomenon of climate change. A new research published by Imperial College London in Nature Communications reveals that bacteria along with archea (together they form prokaryotes) will adapt better to the rising temperatures due to global warming. Rising temperature is likely

PPD partners with the Biopharma Company

Wilmington-based Pharmaceutical Product Development (PPD) as of late reported its coordinated effort with a worldwide clinical-organize biopharmaceutical organization to create oncology and immunology therapeutics. Harbor BioMed (HBM) has chosen PPD as its favored worldwide contract research accomplice to lead clinical investigations on its inside research pipelines, as indicated by a news discharge. The organization is

Shares of the Oncolytics Biotech are up by 8.1 percent

Oncolytics Biotech, Inc. (TSE:ONC’s) stock value shot up 8.1% during noontime exchanging on Friday . The organization exchanged as high as C$0.86 and last exchanged at C$0.80, 140,240 offers exchanged hands during exchanging an expansion of 289 percent from the normal session volume of 36,041 offers. The stock had recently shut at C$0.74.Independently, Royal Bank

Federal Trade Commission issued civil subpoenas to J&J as part of an investigation whether its blockbuster drug violated antitrust laws

Civil subpoenas were issued by FTC to J&J in June as part of scrutiny into whether contracting practices for its bestseller rheumatoid arthritis drug, Remicade, violated antitrust laws, the firm stated in a regulatory filing on Monday. Firm’s shares traded slightly down at $132.47, after having closed up 1.7 percent on Monday. According to Johnson

N.L. biotech looking for family doctors and 2500 people to volunteer their genetic & medical info for research

A Newfoundland & Labrador biotech firm is looking for 2,500 people to volunteer their genetic & medical information for research which seeks to develop novel treatments for common illnesses. The Chief Executive Officer of Sequence Bio, Chris Gardner stated that we are in the search for drug targets. Meaning, if we can identify particular changes

Gilead Sciences Inc. achieved to score a ‘Perfect 10’, weighed by the Smart Score metric

Most investors turn to biotechs when they’re in search of compelling stocks with momentous strategic growth potential. Any firm which employs technology that involves living organisms for creating agricultural or medical products is known as biotech. The S&P Biotech Select Industry Index gained 18 percent over the last decade. Several financial bloggers and analysts believe

University of Technology & PharmaCyte Biotech collaborated to create Advanced Version of Melligen Cells to Treat Diabetes

A clinical-stage biotech firm which is devoted to the development of targeted treatments for cancer & diabetes using its signature live-cell encapsulation technology known as cell-in-a-box, PharmaCyte Biotech, Inc., made an announcement today that has tapped into a new research agreement with the Australia’s University of Technology Sydney to develop a new version of Melligen

Swiss Biotechnology firm gets a patent for the Canadian bio markets

Swiss biotech firm NLS Pharmaceutics Ltd, which spotlights on the improvement of novel medicines for the focal sensory system (CNS)— specifically consideration shortage hyperactivity issue (ADHD) just as hypersomnia (counting narcolepsy, idiopathic hypersomnia, and Kleine Levin disorder)— and other neurological maladies, has gotten a notice of recompense for a patent from the Canadian Intellectual Property